SCHEMBL9968902

SCHEMBL9968902

COC(=O)c1ccc(/C(N)=N/O)c(OC)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.60
MAPT P10636 7/20 0.56
ALDH1A1 P00352 3/20 0.51
KDM4E B2RXH2 2/20 0.51
HSD17B10 Q99714 2/20 0.51
HPGD P15428 2/20 0.51
ATM Q13315 2/20 0.51
GLA P06280 1/20 0.51
CASP1 P29466 1/20 0.51
CASP7 P55210 1/20 0.51
RAB9A P51151 4/20 0.49
NPC1 O15118 3/20 0.49
RECQL P46063 1/20 0.49
KMT2A Q03164 4/20 0.48
POLB P06746 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
CASP3 P42574 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2773580 1.00 GAA (0.60) GAAMAPTALDH1A1KDM4EHSD17B10
SCHEMBL2773585 1.00 GAA (0.60) GAAMAPTALDH1A1KDM4EHSD17B10
SCHEMBL2804346 0.88 MAPT (0.56) GAAMAPTALDH1A1KDM4EHSD17B10
SCHEMBL9968903 0.88 RECQL (0.56) GAAMAPTALDH1A1KDM4EHSD17B10
SCHEMBL9968908 0.88 MAPT (0.56) GAAMAPTALDH1A1KDM4EHSD17B10
SCHEMBL2804345 0.88 MAPT (0.56) GAAMAPTALDH1A1KDM4EHSD17B10
SCHEMBL2773603 0.88 RECQL (0.56) GAAMAPTALDH1A1KDM4EHSD17B10
SCHEMBL30506507 0.88 MAPT (0.56) GAAMAPTALDH1A1KDM4EHSD17B10
SCHEMBL2773601 0.88 RECQL (0.56) GAAMAPTALDH1A1KDM4EHSD17B10
SCHEMBL2471433 0.84 KDM4E (0.54) GAAMAPTALDH1A1KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8202865-B2 Oxadiazole derivatives MERCK SERONO SA (CH) 2012-06-19 US disclosed
US-8202865-B2 Oxadiazole derivatives MERCK SERONO SA (CH) 2012-06-19 US disclosed
US-20100240658-A1 Oxadiazole Derivatives MERCK SERONO SA (CH) 2010-09-23 US disclosed
US-20100240658-A1 Oxadiazole Derivatives MERCK SERONO SA (CH) 2010-09-23 US disclosed
WO-2009043889-A2 OXADIAZOLE DERIVATIVES MERCK SERONO S.A. (CH) 2009-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240658-A1 Oxadiazole Derivatives OXA1L, RO60, NQO2 GAA 3886/4885MAPT 3455/4885ALDH1A1 516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.